Introduction: Cancer is one of the most significant health challenges demanding the expansion of effectual therapeutic methods. Triple-negative breast cancer (TNBC) is a form of aggressive cancer with inadequate therapeutic options which lacks the expression of certain hormones.
Materials And Methods: The present study investigates the potential of naringenin-7-O-glucoside, a flavanone glycoside extracted from as an anticancer agent against TNBC cell lines.